Yahoo
NasdaqCM - Delayed Quote USD

BioNexus Gene Lab Corp. (BGLC)

0.9175 -0.0625 (-6.38%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,126.5810
7,424.9110
9,510.6460
9,770.8060
10,928.7070
Cost of Revenue
2,740.6870
6,339.6940
8,221.1250
8,441.3080
9,669.6780
Gross Profit
385.8940
1,085.2170
1,289.5210
1,329.4980
1,259.0290
Operating Expense
3,111.6140
4,243.6670
3,246.2840
4,409.1220
1,550.2060
Operating Income
-2,725.7200
-3,158.4500
-1,956.7630
-3,079.6240
-291.1770
Net Non Operating Interest Income Expense
52.0200
64.3460
126.4950
54.7460
-12.4790
Other Income Expense
98.5660
109.4970
235.4200
417.3610
--
Pretax Income
-2,575.1340
-2,984.6070
-1,594.8480
-2,607.5170
-303.6560
Tax Provision
--
0
3.4940
21.5260
52.3100
Net Income Common Stockholders
-2,575.1340
-2,984.6070
-1,598.3420
-2,629.0430
-355.9660
Diluted NI Available to Com Stockholders
-2,575.1340
-2,984.6070
-1,598.3420
-2,629.0430
-355.9660
Basic EPS
-1.26
-1.61
-0.90
-1.66
-0.46
Diluted EPS
-1.26
-1.61
-0.90
-1.66
-0.46
Basic Average Shares
2,167.0380
1,856.6800
1,781.8480
1,587.5450
1,440.9730
Diluted Average Shares
2,167.0380
1,856.6800
1,781.8480
1,587.5450
1,440.9730
Total Operating Income as Reported
-2,558.2400
-2,965.0650
-1,573.7020
-2,593.5880
-291.1770
Total Expenses
5,852.3010
10,583.3610
11,467.4090
12,850.4300
11,219.8840
Net Income from Continuing & Discontinued Operation
-2,575.1340
-2,984.6070
-1,598.3420
-2,629.0430
-355.9660
Normalized Income
-2,704.4920
-3,034.6190
-1,732.1134
-2,914.2467
-355.9660
Interest Income
68.9140
83.8880
147.6410
68.6750
--
Interest Expense
16.8940
19.5420
21.1460
13.9290
12.4790
Net Interest Income
52.0200
64.3460
126.4950
54.7460
-12.4790
EBIT
-2,558.2400
-2,965.0650
-1,573.7020
-2,593.5880
-291.1770
EBITDA
-2,381.4130
-2,796.7580
-1,420.5590
-2,485.1650
-185.7580
Reconciled Cost of Revenue
2,740.6870
6,339.6940
8,221.1250
8,441.3080
9,669.6780
Reconciled Depreciation
176.8270
168.3070
153.1430
108.4230
105.4190
Net Income from Continuing Operation Net Minority Interest
-2,575.1340
-2,984.6070
-1,598.3420
-2,629.0430
-355.9660
Total Unusual Items Excluding Goodwill
129.3580
50.0120
176.0150
375.2680
--
Total Unusual Items
129.3580
50.0120
176.0150
375.2680
--
Normalized EBITDA
-2,510.7710
-2,846.7700
-1,596.5740
-2,860.4330
-185.7580
Tax Rate for Calcs
0
0
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0
0
42.2436
90.0643
0
12/31/2022 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: